ClinicalTrials.gg
TerminatedNCT02058797CTFORPROUpdated Jun 2, 2015

Efficacy of Coherence Therapy for Procrastination

An interventional study of Coherence Therapy and Cognitive Behavioral Therapy in Procrastination, sponsored by University of Barcelona. Terminated at 1 site in Spain. Open to participants aged 19 Years to 26 Years. Per ClinicalTrials.gov, last updated 2015-06-02.

Sponsored by University of Barcelona · Not applicable, Interventional, and Treatment

How we know

Why this study was terminated
The Coherence Therapy intervention could not be delivered in a reliable and valid way for a variety of reasons.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
31
Allocation
Randomized
Ages
19 Years to 26 Years
Sex
All
01

Study summary

The purpose of this study is to determine the efficacy of Coherence Therapy in treating procrastination. For that, this intervention is compared to Cognitive-Behavioral Therapy which was already proved to be efficacious in treating this problem. The method used is a randomized controlled trial.

Read the detailed description

Procrastination is a recognized difficulty that entails negative outcomes regarding performance and subjective well-being. In order to find effective treatments for procrastination, the present study wants to test the efficacy of Coherence Therapy, compared with Cognitive Behavioral Therapy. Procrastination, negative emotional states and cognitive structure will be assessed in pre-treatment and post-treatment evaluation. A total of 30 students will be randomly assigned to Coherence Therapy (n=15) or Cognitive Behavioral Therapy (n=15). In both forms of treatment students will receive three weekly sessions and one more session six to seven weeks after the third session. The treatment will be provided by trained psychotherapists. Findings would clarify the effectiveness of Coherence Therapy for the treatment of procrastination and the change of emotional states and cognitive structure of the students after the treatment.

02

Conditions studied

  • Procrastination

Keywords

  • Procrastination
  • Coherence Therapy
  • Cognitive Behavioral Therapy
  • Repertory Grid Technique
  • Cognitive Conflicts
  • Personal Dilemmas
03

In context

Lead sponsor

University of Barcelona is the lead sponsor of 100 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 26 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being a student
  • 19-26 years old
  • A score above 51 on the General Procrastination Scale

Exclusion criteria

Exclusion Criteria:

  • Being currently under a psychological treatment
  • Being diagnosed lately with any mental disorder
  • Mental retardation
  • Substantial visual, hearing or cognitive deficits
  • Psychotic symptoms
  • Organic brain dysfunction
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
31 participants (actual)

Study arms

  • Experimental
    Coherence Therapy

    Individual treatment with Coherence Therapy: three one-hour sessions + one booster session.

    Behavioral: Coherence Therapy

  • Active comparator
    Cognitive Behavioral Therapy

    Individual treatment with Cognitive Behavioral Therapy: three one-hour sessions + one booster session.

    Behavioral: Cognitive Behavioral Therapy

Interventions

  • BehavioralCoherence Therapy

    Manualized individual treatment (3 + 1 one-hour sessions)

  • BehavioralCognitive Behavioral Therapy

    Manualized individual treatment (3 + 1 one-hour sessions)

06

What researchers measure

Primary outcomes

  1. General Procrastination Scale (Lay, 1986)

    Change from Baseline in General Procrastination Scale measured before and after the therapy in order to determine the level of general procrastination.

    Time frame: Post-treatment assessment (10-12 weeks)

Other outcomes

  1. Repertory Grid Technique (Kelly, 1995; adaptation of Feixas & Cornejo, 1996)

    Change in cognitive structure measured by Kelly's Repertory Grid Technique.

    Time frame: Post-treatment assessment (10-12 weeks)

  2. Depression, Anxiety and Stress Scale (Lovibond & Lovibond, 1995)

    Change from Baseline in negative emotional states on three dimensions: depression, anxiety and stress.

    Time frame: Post-treatment assessment (10-12 weeks)

07

Study locations

1 site
  • University of Barcelona
    Barcelona, Catalonia 08035, Spain
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2014, a primary completion of Jun 2014 and a completion of Jun 2014. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 6, 2014
First posted
Feb 10, 2014
Start
Jan 2014
Primary completionActual
Jun 2014
CompletionActual
Jun 2014
Last update
Jun 2, 2015
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 2, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02058797
Responsible party
Dr. Guillem Feixas (Professor, University of Barcelona) — Principal investigator
First posted
Feb 10, 2014
Start date
Jan 2014
Primary completion
Jun 2014
Completion
Jun 2014
Last update
Jun 2, 2015

Study contacts

Guillem Feixas, Ph.D.
principal investigator · University of Barcelona

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jun 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion